Loss of the Endothelial Glucocorticoid Receptor Prevents the Therapeutic Protection Afforded by Dexamethasone after LPS
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Glucocorticoids are normally regarded as anti-inflammatory therapy for a wide variety of conditions and have been used with some success in treating sepsis and sepsis-like syndromes. We previously demonstrated that mice lacking the glucocorticoid receptor in the endothelium (GR EC KO mice) are extremely sensitive to low-dose LPS and demonstrate prolonged activation and up regulation of NF-κB. In this study we pre-treated these GR EC KO mice with dexamethasone and assessed their response to an identical dose of LPS. Surprisingly, the GR EC KO mice fared even worse than when given LPS alone demonstrating increased mortality, increased levels of the inflammatory cytokines TNF-α and IL-6 and increased nitric oxide release after the dexamethasone pre-treatment. As expected, control animals pre-treated with dexamethasone showed improvement in all parameters assayed. Mechanistically we demonstrate that GR EC KO mice show increased iNOS production and NF-κB activation despite treatment with dexamethasone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Importantly, the presence of endothelial GR is required for dexamethasone to rescue the animals from lipopolysaccharide (LPS)-induced morbidity and mortality [24].”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 1×
“In human trials, steroids have been used with considerably less success in this setting for many decades, as the mechanisms by which they confer their anti-inflammatory effects are still not clear [4,5].”
BackgroundGenomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Possible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville-Nash, P. R., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 749
The Human Glucocorticoid Receptor β Isoform
Oakley, R. H., Sar, M., & Cidlowski, J. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9550 · Cited by 562
Webster, J. C., Oakley, R. H., Jewell, C. M., & Cidlowski, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121455098 · Cited by 482
Nuclear Factor Kappa B: Important Transcription Factor and Therapeutic Target
Lee, J., & Burckart, G. J. (1998) · The Journal of Clinical Pharmacology · doi:10.1177/009127009803801101 · Cited by 365
Loss of Akt1 Leads to Severe Atherosclerosis and Occlusive Coronary Artery Disease
Fernández-Hernando, C., Ackah, E., Yu, J., Suárez, Y., Murata, T., Iwakiri, Y., Prendergast, J., Miao, R. Q., Birnbaum, M. J., & Sessa, W. C. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.007 · Cited by 284
Self-citationExpression and Subcellular Distribution of the β-Isoform of the Human Glucocorticoid Receptor*
Oakley, R. H., Webster, J. C., Sar, M., Parker, C. R., & Cidlowski, J. A. (1997) · Endocrinology · doi:10.1210/endo.138.11.5501 · Cited by 193
Genetic dissection of glucocorticoid receptor function in mice
Tronche, F., Kellendonk, C., Reichardt, H. M., & Schütz, G. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80007-5 · Cited by 180
Evolution of glucocorticoid receptors with different glucocorticoid sensitivity
Stolte, E. H., van Kemenade, B. M. L. V., Savelkoul, H. F. J., & Flik, G. (2006) · Journal of Endocrinology · doi:10.1677/joe.1.06703 · Cited by 162
Crosstalk between NFkB and glucocorticoid signaling: A potential target of breast cancer therapy
Ling, J., & Kumar, R. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.033 · Cited by 155
Abandon the Mouse Research Ship? Not Just Yet!
Osuchowski, M. F., Remick, D. G., Lederer, J. A., Lang, C. H., Aasen, A. O., Aibiki, M., Azevedo, L. C., Bahrami, S., Boros, M., Cooney, R., et al. (2014) · Shock · doi:10.1097/shk.0000000000000153 · Cited by 143
Endothelial glucocorticoid receptor is required for protection against sepsis
Goodwin, J. E., Feng, Y., Velazquez, H., & Sessa, W. C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210200110 · Cited by 142
Self-citationChauhan, S. D., Seggara, G., Vo, P. A., Macallister, R. J., Hobbs, A. J., & Ahluwalia, A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0668fje · Cited by 142
Glucocorticoids: do we know how they work?
Saklatvala, J. (2002) · Arthritis Research & Therapy · doi:10.1186/ar398 · Cited by 135
Discovery of Glucocorticoid Receptor-β in Mice with a Role in Metabolism
Hinds, T. D., Ramakrishnan, S., Cash, H. A., Stechschulte, L. A., Heinrich, G., Najjar, S. M., & Sanchez, E. R. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0411 · Cited by 129 · cited 4×
“As in humans, this isoform is unresponsive to the glucocortioid agonist DEX and is able to inhibit GRa under some conditions [15].”
BackgroundMethodInfluentialSchäkermann, S., Schäkermann, M., & Narberhaus, F. (2010) · Journal of Bacteriology · doi:10.1128/jb.01043-10 · Cited by 82
EFFECTS OF BACTERIAL ENDOTOXINS ON METABOLISM
Berry, L. J., & Smythe, D. S. (1964) · The Journal of Experimental Medicine · doi:10.1084/jem.120.5.721 · Cited by 73
EXPERIMENTAL STUDIES ON THE SIGNIFICANCE OF ENDOTOXIN IN THE PATHOGENESIS OF BRUCELLOSIS
Spink, W. W., & Anderson, D. (1954) · Journal of Clinical Investigation · doi:10.1172/jci102924 · Cited by 72
Guerrero, J., Gatica, H. A., Rodríguez, M., Estay, R., & Goecke, I. A. (2013) · Critical Care · doi:10.1186/cc12774 · Cited by 71 · cited 1×
“Recent work has also suggested that the presence of the b isoform of the glucocorticoid receptor may be responsible for glucocorticoid resistance under some conditions, including in human septic shock [21,22].”
BackgroundGlucocorticoid receptor represses proinflammatory genes at distinct steps of the transcription cycle
Gupte, R., Muse, G. W., Chinenov, Y., Adelman, K., & Rogatsky, I. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309898110 · Cited by 70 · cited 1×
“New data suggests that perhaps the anti-inflammatory actions of GR cannot be explained by a unifying mechanism but that characteristics of target genes and transcriptional state may provide situation-specific repression [29].”
BackgroundWang, X., Nelin, L. D., Kuhlman, J. R., Meng, X., Welty, S. E., & Liu, Y. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.09.003 · Cited by 61
Protective roles of nitric oxide and testosterone in endotoxemia: evidence from NOS-2-deficient mice
Laubach, V. E., Foley, P. L., Shockey, K. S., Tribble, C. G., & Kron, I. L. (1998) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1998.275.6.h2211 · Cited by 56
Goodwin, J. E., Zhang, J., Gonzalez, D., Albinsson, S., & Geller, D. S. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328347da54 · Cited by 56
Self-citationGlucocorticoid signaling in myeloid cells worsens acute CNS injury and inflammation
Sorrells, S. F., Caso, J. R., Munhoz, C. D., Hu, C. K., Tran, K. V., Miguel, Z. D., Chien, B. Y., & Sapolsky, R. M. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4705-12.2013 · Cited by 46 · cited 1×
“A similar deleterious effect has been found in acute brain injury, whereby administration of steroids has been found to augment inflammation [28].”
BackgroundTissue Expression of Endothelin-1 mRNA in Endotoxaemia
Kaddoura, S., Curzen, N. P., Evans, T. W., Firth, J. D., & Poole-Wilson, P. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0115 · Cited by 40
Taniguchi, Y., Iwasaki, Y., Tsugita, M., Nishiyama, M., Taguchi, T., Okazaki, M., Nakayama, S., Kambayashi, M., Hashimoto, K., & Terada, Y. (2010) · Endocrinology · doi:10.1210/en.2009-1254 · Cited by 36
Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone
Ohana, Y. H., Deshet‐Unger, N., Souroujon, M. C., Mittelman, M., & Neumann, D. (2014) · Scientific Reports · doi:10.1038/srep04323 · Cited by 32
Bonin, C. P., Baccarin, R. Y. A., Nostell, K. E. A., Nahum, L. A., Fossum, C., & Camargo, M. M. D. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.002 · Cited by 21
Dexamethasone antagonism of glucose dyshomeostasis in endotoxin shock.
Figlewicz, D. P., & Filkins, J. P. (1978) · PubMed · Cited by 6
Cited by
Annane, D., Pastores, S. M., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., Carcillo, J., Christ-Crain, M., Cooper, M. S., Marik, P. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4914-x · Cited by 220
Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy
Srivastava, S. P., Zhou, H., Setia, O., Liu, B., Kanasaki, K., Koya, D., Dardik, A., Fernandez-Hernando, C. F., & Goodwin, J. E. (2021) · Nature Communications · doi:10.1038/s41467-021-22617-y · Cited by 152
Self-citationThe Glucocorticoid Receptor in Cardiovascular Health and Disease
Liu, B., Zhang, T., Knight, J. K., & Goodwin, J. E. (2019) · Cells · doi:10.3390/cells8101227 · Cited by 149
Self-citationAnnane, D., Pastores, S. M., Arlt, W., Balk, R. A., Beishuizen, A., Briegel, J., Carcillo, J., Christ-Crain, M., Cooper, M. S., Marik, P. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002724 · Cited by 117
Endothelial Response to Glucocorticoids in Inflammatory Diseases
Zielińska, K. A., Moortel, L. V., Opdenakker, G., Bosscher, K. D., & den Steen, P. E. V. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00592 · Cited by 132
Metadata
- Authors
- Goodwin, J. E., Feng, Y., Velazquez, H., Zhou, H., & Sessa, W. C.
- Affiliations
- Yale University (US)
- Corresponding author
- Goodwin, Julie E.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-10-09
- Volume
- 9
- Issue
- 10
- Pages
- e108126
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4191990
- OpenAlex
- W1987467309
- Cited by
- 19
- References
- 30
- Citations by year
- 2025: 1 · 2022: 1 · 2021: 6 · 2019: 2 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 1
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Yale University (P30 DK079310)
- National Institutes of Health (PO1 HL107205, HL107205, HL61371, HL64793, HL081190)
- National Heart, Lung, and Blood Institute (HL-081190, HL-61371, R01HL096670, HL-64793, R01HL064793, R01HL081190, HL096670, R01HL061371, P01HL107205, R37HL061371)
- National Institute of Diabetes and Digestive and Kidney Diseases (U24DK59635, U24DK059635, K08DK078623, P30DK079310)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- dexamethasone, lipopolysaccharide, sepsis, NF-κB activation, inducible nitric oxide synthase, nitric oxide, TNF-α, interleukin-6, anti-inflammatory therapy
- MeSH terms
- Animals, Anti-Inflammatory Agents, Dexamethasone, Endothelium, Glucocorticoids, Lipopolysaccharides, Male, Nitric Oxide, Receptors, Glucocorticoid, Tumor Necrosis Factor-alpha, Interleukin-6, NF-kappa B, Sepsis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.